news

Compound combination successful against Pseudomonas aeruginosa

Researchers have developed a new combination of compounds called AB569 which has demonstrated success at fighting deadly pathgoens like Pseudomonas aeruginosa.

Pseudomonas aeruginosa in petri dish

An international team of researchers has found a combination of therapeutic ingredients called AB569 can kill bacteria, presenting an option for tackling superbug infections that are resistant to antibiotics. Made from both acidified nitrite and ethylenediaminetetraacetic acid (EDTA), AB569 was developed by researchers at the University of Cincinnati (UC), US, to combat Pseudomonas aeruginosa. 

In the study, AB569 was tested against several Gram-negative and Gram-positive bacteria and was successful at inhibiting all. Pseudomonas aeruginosa was also applied to the lungs of laboratory mice for five days. This bacteria is considered one of the most resistant and deadly to humans. 

The combined compounds killed the pathogenic bacteria by targeting their DNA, RNA and protein biosynthesis as well as energy and iron metabolism. Further electrochemical analyses showed that AB569 produced more stable SNO proteins, which the researchers say potentially explains one mechanism of action for killing bacteria. 

 

Reserve your FREE place

 


Are you looking to optimise antibody leads in your drug discovery? Register for this webinar to find out how!

30 July 2025 | 10:00 AM BST | FREE Webinar

Join this webinar to hear from Dr. Lei Guo as she shares how early insights into liability, PK, stability, and manufacturability can help you optimise antibody leads in early drug discovery – and mitigate downstream risks later in development.

What You’ll Learn:

  • How to assess key developability risks early
  • How in silico modelling and in vitro testing can be combined to predict CMC risks earlier in discovery stage
  • How micro-developability strategies are tailored for complex or novel formats

Don’t miss your chance to learn from real-world leaders

Register Now – It’s Free!

 

According to the team, the combined compounds were successful against the pathogens at concentrations which hold no toxicity for human cells. 

“These were tested in laboratory mice with humanised cells. Our data implicate that AB569 is a safe and effective means that could be applied to eradicate these superbugs,” said senior author Daniel Hassett, a professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology.

…the combined compounds were successful against the pathogens at concentrations which hold no toxicity for human cells”

Pseudomonas aeruginosa is considered one of six ESKAPE pathogens, known by their acronym and considered among the most resistant and deadly to humans. The ESKAPE pathogens include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanniiPseudomonas aeruginosa and Enterobacter spp.

“These superbugs have an ingenious mechanism of being able to resist traditional antibiotic therapies by a vast number of acquired strategies,” explained Hassett. “Antibiotics affect specific processes in the bacteria, but not all of them. AB569 affects multiple processes at once leaving the exposed bacteria simply overwhelmed.”

The findings appear in Proceedings of the National Academy of Sciences of the United States of America.

Leave a Reply

Your email address will not be published. Required fields are marked *